Radiopharm Theranostics RADX
NASDAQ RADX
$1.49 -0.13 (-8.02%)
As of: Oct 1, 2026 · 12:00 PM EDT

Radiopharm Theranostics (RADX) Shares Outstanding (2023 - 2026)

Updated

Radiopharm Theranostics (RADX) recorded Shares Outstanding of 2.08 billion in fiscal Q4 2026 (quarter ended Jun 30, 2026), unchanged from 2.08 billion a year earlier.

Analysis

Radiopharm Theranostics (RADX) Shares Outstanding (2023 - 2026) Analysis & Trends

Starting with fiscal Q4 2023, Radiopharm Theranostics' Shares Outstanding history includes 5 quarters.

  • Annual Shares Outstanding has a three-year compound annual growth rate of 89.5% (FY2023 to FY2026).
  • Across earlier fiscal years, Shares Outstanding came in at 2.08 billion in FY2025 (+438.5%), 386.46 million in FY2024 (+26.4%) and 305.83 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.94 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.70 Mn
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86 3.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.08 Bn
Jun 30, 2025 2.08 Bn
Dec 31, 2024 386.46 Mn
Jun 30, 2024 386.46 Mn
Jun 30, 2023 305.83 Mn
API Access

Radiopharm Theranostics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=RADX&period=max&api_key=YOUR_API_KEY